State of the Art and Emerging Directions in Screening

Andrew Vickers, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

Next Generation Biomarkers: As Reflex, Combination, or First Line?

E. David Crawford MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

The Live Primary Cell Phenotypic Test (LPCP)

David Albala, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

High Resolution 29MHz Micro-Ultrasound

E. David Crawford, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

Multi-Parametric MRI

Masoom Haider, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

Molecular Imaging of Prostate Cancer

Wolfgang Weber, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

Image-Guided Biopsy and Treatment

Daniel Margolis, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

Precision Radiation Therapy: Low to Intermediate Risk Prostate Cancer

Michael Zelefsky, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

High Risk Prostate Cancer: Emphasis on Radiation Oncology

Daniel Margolis, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

High Risk Prostate Cancer: Emphasis on Medical Oncology

David M. Nanus, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019, in Boston, MA.

SESSION II. PATIENT POPULATION PRIOR TO DIAGNOSIS OF PROSTATE CANCER: Screening and Clinical Evaluation of Men with Clinical Suspicion

Focal Therapy vs. Active Surveillance: Role of the Urologist

Jim C. Hu, MD, MPH, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

State of the Art in “Smart” Prostate Cancer Screening: Defining the Need for Precision Diagnostics

Sigrid V. Carlsson, MD, PHD, MPH, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Current and Emerging Imaging Tools for Improving Risk Assessment

Sangeet Ghai, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Contrast Enhanced Ultrasound of the Prostate

Ethan J. Halpern, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Integration of PSA and PI-RADs for Risk Assessment of Prostate Cancer

Jeffrey Weinreb, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Artificial Intelligence-Based Automated Reading

Liang Wang, MD, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Review of the Role of MRI-Targeted Biopsy vs Systematic Biopsy

Mukesh Harisinghani, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Update of Changes in the Early Detection of Prostate Cancer NCCN Guidelines

Preston C. Sprenkle, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Integrating MRI and Molecular Markers to Detect Aggressive Prostate Cancer

Sanoj Punnen, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

SESSION III. CLINICAL EVALUATION AND MANAGEMENT OF MEN WITH LOCALIZAED RECURRENT AND OLIGOMETASTATIC PROSTATE CANCER

Non-Invasive Molecular Imaging- Fluciclovine

Gerald L. Andriole, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Prostate Cancer Initial Staging and Evaluation of Recurrent Disease with PSMA Targeted PET

Steven Rowe, MD, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Considerations for the Clinical Impact of Next Generation Imaging in Prostate Cancer

Ashley Ross, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Intra-Operative Molecular Imaging

Wolfgang Weber, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Radiation Oncology Perspective on Treatment Planning of Localized Disease

Ashesh B. Jani, MD, MSEE, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Radiation Oncology Perspective on Treatment of Oligometastatic Disease

Jason Efstathiou, MD, D. Phil., presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Radiomics and Machine Learning

Masoom Haider, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Pathology Perspective on Pathologic Assessment and Patient Outcomes

Thomas Wheeler, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Restricted Mean Survival Times as the Novel Measure of Patient Outcomes

Jennifer Rider, ScD, MPH, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Radiogenomics in Active Surveillance: How Can We Integrate mpMRI and Genomics to Monitor Prostate Cancer

Sanoj Punnen, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Radiogenomics: The Emerging and Future Impact on Treatment Selection and Monitoring in Focal Therapy

Fiona Fennessy, MD, BCh, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Tumor Habitat-Targeted Radiotherapy for Prostate Cancer

Alan Pollack, MD, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Radiogenomics: Impact on Treatment Selection and Monitoring – Urologic Perspective

Adam S. Feldman, MD, MPH, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Quality Improvement in Prostate Cancer – A National Veterans Hospital Iniative

Sadhna Verma, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Multi-Center MRI-Integrative Nomogram for ECE of Prostate Cancer

Amita Dave, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

Novel Emerging Approaches to Focal Treatment

Art Rastinehad, DO, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 4, 2019, in Boston, MA.

SESSION IV. PRECISION DIAGNOSTICS AND EMERGING ROLE OF FOCAL TREATMENT

Current and Emerging Role of Radiogenomics

John Feller, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Surveillance After Focal Therapy of Prostate Cancer

Abhinav Sidana, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Radiology Perspective of Clinical Role of Focal Treatment

Aytekin Oto, MD, MBA, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Focal Treatment of Prostate Cancer: The Case for Radiotherapy

Daniel Y. Song, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Focal Therapy vs. Active Surveillance: Role of the Urologist

Jim C. Hu, MD, MPH, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Standard Treatment for Advanced Prostate Cancer

David Nanus, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Overview of Treatment for Advanced Prostate Cancer, including Metastatic Disease – Novel Treatment

Christopher Sweeney, MD, MBBS, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Liquid Biomarkers – Including Circulating Tumor Cells and Germline Testing

David Nanus, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Exosomal Liquid Biopsy in Prostate Cancer: Role in Prostate Biopsy Decision Making

Judd Moul, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Prostate Specific PET Imaging Overview: Next Step in Defining Clinical Uility

Christopher Sweeney, MD, MBBS, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

PSMA-11 PET: Atypical Paths to FDA Approval and Academic NDAs

Thomas Hope, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Theranostics of Prostate Cancer – Current State of the Art

Wolfgang Weber, MD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.

Bioinformatics for a Multi-Modality Approach to Precision Diagnosis and Treatment, Including Radiogenomics

Paul Boutros, MD, PhD, presented this lecture during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 5, 2019, in Boston, MA.